The CurePSP New Investigator Award supports early career researchers conducting innovative studies on the biology, mechanisms, and treatment development for PSP and CBD.
Funder: CurePSP
Due Dates: October 15, 2026 (Full proposal submission deadline, 5:00 PM ET)
Funding Amounts: Up to $100,000 for one- or two-year projects; direct costs only, no indirects.
Summary: Supports early career researchers with innovative pilot or proof-of-concept studies on progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
The CurePSP New Investigator Award grant program is designed to provide seed funding for early career investigators pursuing innovative research in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). The program aims to help researchers generate foundational data that will qualify them for larger-scale funding opportunities. Projects may focus on fundamental neurobiology, molecular and cellular mechanisms, or translational research accelerating the development of new therapeutics and biomarkers for PSP and CBD. Both U.S. and international applicants are eligible, provided they meet the early career criteria.